Impact of Treatment Acceleration and its Timing on the Response of the Rhabdomyosarcoma R1H of the Rat to Fractionated Irradiation

@article{Raabe2001ImpactOT,
  title={Impact of Treatment Acceleration and its Timing on the Response of the Rhabdomyosarcoma R1H of the Rat to Fractionated Irradiation},
  author={Annette Raabe and Sylvai Quaester and H. -H. Dubben and J{\"o}rg Olaf Zieron and Andreas Kruell and Winfried A Alberti and Hans-Peter Beck-Bornholdt},
  journal={Strahlentherapie und Onkologie},
  year={2001},
  volume={177},
  pages={362-366}
}
In clinical practice a concomitant boost is usually given as a second daily dose to a reduced field. The question arises which part of treatment should be accelerated to achieve optimal tumor control. An experiment was performed on tumor bearing rats to determine the optimal timing of treatment acceleration for this experimental tumor system. Material and Methods: Rhabdomyosarcoma R1H of the rat were treated applying 30 fractions in an overall treatment time of 40–42 days. Up to total ranging… CONTINUE READING